fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptikumok, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
imicilex 500 mg/500 mg por oldatos infúzióhoz
pharmacenter europe kft. - cilastatin sodium; imipenem -
imipenem/cilastatin anfarm 500 mg/500 mg por oldatos infúzióhoz
anfarm hellas s.a. - cilastatin; imipenem -
spiriva 18 mikrogramm inhalációs por kemény kapszulában
boehringer ingelheim international gmbh - tiotropium-bromid -
sp 54 bevont tabletta
kéri pharma hungary kft. - pentozán-poliszulfát-nátrium -
sp 54 oldatos injekció
bene arzneimittel gmbh - pentozán-poliszulfát-nátrium -
aktil 250 mg/125 mg filmtabletta
sandoz hungária kft. - egyesülnek -
amitrex 100 mg tabletta
sanofi-aventis zrt. - amisulpride -
amitrex 200 mg tabletta
sanofi-aventis zrt. - amisulpride -
amitrex 400 mg filmtabletta
sanofi-aventis zrt. - amisulpride -